<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05060302</url>
  </required_header>
  <id_info>
    <org_study_id>PI2021_843_0030</org_study_id>
    <nct_id>NCT05060302</nct_id>
  </id_info>
  <brief_title>Prognosis of Right Ventricular Dysfunction Assessed by Speckle Tracking in Postoperative Thoracic Surgery</brief_title>
  <acronym>SPECKLETHO</acronym>
  <official_title>Prognosis of Right Ventricular Dysfunction Assessed by Speckle Tracking in Postoperative Thoracic Surgery: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In postoperative thoracic surgery (lobe resection, pneumonectomy or wedge resection),&#xD;
      cardiovascular complications are the most frequent (10 to 15%) with a significant&#xD;
      morbi-mortality rate. Right ventricular (RV) dysfunction is a complication that can be&#xD;
      multifactorial in post thoracic surgery. The RV longitudinal shortening fraction (RV-LSF) is&#xD;
      a new 2D-STE parameters able to more accurately detect patients with RV dysfunction compared&#xD;
      to conventional echocardiographic parameters.&#xD;
&#xD;
      This project is a single-center, prospective, interventional study of patients hospitalized&#xD;
      at the Amiens University Hospital for scheduled thoracic surgery. TTE is performed&#xD;
      preoperatively, at day 2 and day 15 following the thoracic surgery. Echocardiographic&#xD;
      parameters will be measured by an echocardiographic expert in offline with a dedicated&#xD;
      software. MACE criteria will be collected at day 2, day 15 and day-30 following the thoracic&#xD;
      surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 15, 2021</start_date>
  <completion_date type="Anticipated">September 2024</completion_date>
  <primary_completion_date type="Anticipated">September 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>occurrence of a major cardiovascular event (MACE)</measure>
    <time_frame>day 30</time_frame>
    <description>MACE is a composite criteria. MACES criteria is defined as the occurrence of at least one of the following events: A cardiovascular death or a documented supraventricular tachycardia (atrial fibrillation and/or flutter) of duration &gt; 30 seconds or, an acute myocardial infarction or, an hospitalization for a right ventricular failure or, an hospitalization for a left ventricular failure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Variation of RV systolic function from baseline in patients with MACE</measure>
    <time_frame>at day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation of RV systolic function from baseline in patients without MACE</measure>
    <time_frame>at day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation of RV systolic function from baseline in patients with MACE</measure>
    <time_frame>at day 2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation of RV systolic function from baseline in patients without MACE</measure>
    <time_frame>at day 2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation of RV systolic function from baseline in patients with MACE</measure>
    <time_frame>at day 15</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation of RV systolic function from baseline in patients without MACE</measure>
    <time_frame>at day 15</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation of RV systolic function from baseline in patients with MACE</measure>
    <time_frame>within day 30</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation of RV systolic function from baseline in patients without MACE</measure>
    <time_frame>within day 30</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of RV systolic function preoperatively</measure>
    <time_frame>at day 30</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>occurrence of a postoperative complication</measure>
    <time_frame>at day 30</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">164</enrollment>
  <condition>Right Ventricle</condition>
  <condition>Thoracic Surgery</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>transthoracic echocardiography (TTE)</intervention_name>
    <description>the included patients have a TTE preoperatively in order to evaluate the RV systolic function. TTE will also be done at day 2 and day-15 during the follow-up surgical consultation.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patient (&gt;18 years)&#xD;
&#xD;
          -  Patient hospitalized at the Amiens University Hospital for scheduled thoracic surgery&#xD;
             (lobectomy, pneumonectomy, wedge resection).&#xD;
&#xD;
          -  Surgery by thoracotomy or video-assisted thoracic surgery&#xD;
&#xD;
          -  Information of the patient and collection of his non-opposition&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with poor echogenicity on TTE not allowing evaluation of 2D-STE or&#xD;
             conventional parameters of the RV.&#xD;
&#xD;
          -  Patient with a rapid supraventricular rhythm disorder (HR &gt; 100) at the time of TTE&#xD;
&#xD;
          -  Patient under mechanical ventilation&#xD;
&#xD;
          -  Patient under extracorporeal membrane oxygenation&#xD;
&#xD;
          -  Patients under guardianship or legal protection&#xD;
&#xD;
          -  Patients whose clinical condition does not allow for their non-opposition&#xD;
&#xD;
          -  Pregnant women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christophe Beyls, MD</last_name>
    <phone>0322087866</phone>
    <email>Beyls.Christophe@chu-amiens.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Amiens Picardie</name>
      <address>
        <city>Amiens</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe Beyls, MD</last_name>
      <phone>0322087866</phone>
      <email>Beyls.Christophe@chu-amiens.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 15, 2021</study_first_submitted>
  <study_first_submitted_qc>September 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 29, 2021</study_first_posted>
  <last_update_submitted>September 24, 2021</last_update_submitted>
  <last_update_submitted_qc>September 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Right ventricle</keyword>
  <keyword>speckle tracking</keyword>
  <keyword>thoracic surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ventricular Dysfunction</mesh_term>
    <mesh_term>Ventricular Dysfunction, Right</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

